Please Subscribe to get a daily link to Pat's blog via email


Your privacy is important to us. We will never spam you and keep your personal data secure.


30 07, 2013

What’s a billion dollars among friends?

Tags: , , , , |8 Comments

Ever take Revlimid?  Wonder where the tens of thousands of dollars that Medicare or your private insurance company pays for it goes each month?  To finance speculative acquisitions of small, start-up pharmaceutical companies, of course! A few short weeks after acquiring the rights to one of the hottest yet unproven anti-myeloma therapy agents, MorphoSys' MOR202,

1 07, 2013

More about MOR202

Tags: , , , |1 Comment

Yesterday's post generated quite a bit of interest.  Here's what I know about CD38 and MOR202  In January 2012, a 19 year old company that specializes in human antibody research, MorphoSys, received a U.S. patent for MOR202, a fully human HuCAL antibody.  This new antibody was designed to use CD38 as a therapeutic target for

3 12, 2010

Experimental Anti-Body, MOR202, To Be Featured In New Phase One Study Next Year

Tags: , , , , |0 Comments

Hello from cold (for Florida) sunny Orlando!  ASH starts later today, but I'm getting an early start.  Still plenty to learn and share. For those of you who just can't get enough multiple myeloma related technical information, here is a link to a power point presentation about an experimental anti-myeloma anti-body, MOR202.Lots of photos, charts and graphs.